Events and conventions

Non solo melanoma 2025: Innovative Therapies in Dermato-Oncology

Published

2 years ago

February 18, 2025

Redazione

Cutaneous oncology is a constantly evolving field, characterized by a rising incidence of primary skin tumors and the introduction of increasingly advanced methods for diagnosis and treatment. Turin will host Non solo melanoma 2025: Innovative Therapies in Dermato-Oncology on February 21-22, 2025. This highly relevant ECM (Continuing Medical Education) training event for industry specialists will take place at the Starhotels Majestic on Corso Vittorio Emanuele II, 54. The conference represents a key opportunity to discuss the latest diagnostic and therapeutic innovations in the treatment of skin cancers.

Focus on Cutaneous Oncology and the Multidisciplinary Approach

The course aims to address the challenges related to early diagnosis and advanced management of these diseases, with a particular focus on methods such as confocal laser microscopy, skin-directed therapies, new targeted drugs, and immunotherapies.

The two-day training will begin with a focus on the Piedmont and Aosta Valley Oncology Network. This will be followed by a keynote lecture on new pharmacological strategies, balancing innovation and sustainability.

“Non solo melanoma”: A High-Level ECM Event

The event will highlight how a multidisciplinary approach is essential to ensuring the best possible therapeutic strategy for patients. While these new therapeutic options expand the range of solutions available to dermatologists and oncologists, they also require appropriate and economically sustainable use.

Non solo melanoma, made possible with the unconditional support of Revée, is a key event that will award 8.4 ECM credits. It is open to a maximum of 150 participants, including Medical Doctors specialising in: pathological anatomy, clinical biochemistry, general surgery, plastic and reconstructive surgery, palliative care, dermatology and venereology, oncology, otolaryngology, radiodiagnostics, and radiotherapy.

Biologists, hospital pharmacists, and nurses are also invited to attend. Registration is mandatory and must be completed by February 19, 2025.